SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-338977
Filing Date
2017-11-09
Accepted
2017-11-09 17:08:54
Documents
70
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d457143d10q.htm 10-Q 475830
2 EX-10.3 d457143dex103.htm EX-10.3 39000
3 EX-10.4 d457143dex104.htm EX-10.4 39081
4 EX-31.1 d457143dex311.htm EX-31.1 9856
5 EX-31.2 d457143dex312.htm EX-31.2 9585
6 EX-32.1 d457143dex321.htm EX-32.1 4145
7 EX-32.2 d457143dex322.htm EX-32.2 4161
  Complete submission text file 0001193125-17-338977.txt   4130102

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alt-20170930.xml EX-101.INS 634864
9 XBRL TAXONOMY EXTENSION SCHEMA alt-20170930.xsd EX-101.SCH 48439
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20170930_cal.xml EX-101.CAL 77965
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20170930_def.xml EX-101.DEF 218481
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20170930_lab.xml EX-101.LAB 461428
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20170930_pre.xml EX-101.PRE 345293
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 171191816
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences